Extensively Drug-Resistant Acinetobacter baumannii Nosocomial Pneumonia Successfully Treated with a Novel Antibiotic Combination
Noor Zaidan, J. Patrik Hornak, David Reynoso
Abstract
Extremely drug-resistant (XDR) Acinetobacter baumannii causes challenging nosocomial infections. We report the case of a patient with XDR A. baumannii pneumonia and septic shock successfully treated with cefiderocol and a novel antibiotic obtained via expanded access protocol. With focused research and drug development efforts, the poor outcomes associated with these infections may be mitigated.
Topics & Concepts
Acinetobacter baumanniiPneumoniaAntibioticsSeptic shockMedicineAcinetobacterDrugDrug resistancePseudomonas aeruginosaMicrobiologyIntensive care medicineSepsisBiologyBacteriaImmunologyPharmacologyInternal medicineGeneticsAntibiotic Resistance in BacteriaNosocomial Infections in ICUPneumonia and Respiratory Infections